Pediatric Gastroenterology and Cystic Fibrosis Unit, Policlinico G. Martino Hospital, University of Messina, Via Consolare Valeria 1, 98125, Messina, Italy.
Pharmacy Department, University of Bari, Bari, Italy.
BMC Gastroenterol. 2020 Apr 6;20(1):86. doi: 10.1186/s12876-020-01244-9.
BACKGROUND: Rome IV criteria for functional gastrointestinal disorders state that children suspected of having Irritable Bowel Syndrome (IBS) with Constipation (IBS-C) should be preliminarily treated for constipation. We aimed at verifying if functional constipation may indeed lead to an erroneous diagnosis of IBS with diarrhea (IBS-D) or IBS with mixed pattern of diarrhea and constipation (IBS-M). METHODS: We prospectively enrolled in an unblinded fashion 10 and 16 consecutive children referred to our center who met Rome IV criteria for a diagnosis of IBS-D and IBS-M, respectively. Patients who fulfilled criteria for suspect "occult constipation" were then given a bowel cleaning regimen with Polyethylene glycol 3350, re-evaluated at 2 months and followed up for at least 6 months. Sixteen additional patients with IBS with Constipation (IBS-C) referred in the same period served as control. The endpoints were: 1) a decrease of more than 50% in abdominal pain intensity and frequency scores; and 2) for patients with IBS-D and IBS-M: resolution of diarrhea. RESULTS: The endpoints were met by 8 (80%) and 14 (87%) of the patients with IBS-D and IBS-M, respectively, with decrease of abdominal pain and resolution of "diarrhea". The response was not significantly different from that observed in 15 (93%) of the IBS-C control group. CONCLUSION: Acknowledging the limitations of the small number of patients and of the uncontrolled nature of the study, we suggest that a possibly large number of patients labeled as IBS-D or IBS-M may actually simply present functional constipation and should be managed as such.
背景:罗马 IV 功能性胃肠病诊断标准指出,疑似患有便秘型肠易激综合征(IBS-C)的儿童应先进行便秘治疗。我们旨在验证功能性便秘是否确实会导致腹泻型肠易激综合征(IBS-D)或腹泻便秘混合模式肠易激综合征(IBS-M)的误诊。
方法:我们前瞻性地纳入了 10 名和 16 名连续就诊的符合罗马 IV 标准诊断为 IBS-D 和 IBS-M 的儿童,这些儿童均为非盲法。然后,对符合疑似“隐匿性便秘”标准的患者给予聚乙二醇 3350 肠道清洁方案,在 2 个月时重新评估,并至少随访 6 个月。同期纳入 16 名 IBS-C 患者作为对照。终点为:1)腹痛强度和频率评分降低 50%以上;2)对于 IBS-D 和 IBS-M 患者:腹泻缓解。
结果:IBS-D 和 IBS-M 患者分别有 8 例(80%)和 14 例(87%)达到终点,腹痛减轻,“腹泻”缓解。与 IBS-C 对照组的 15 例(93%)相比,反应无显著差异。
结论:尽管存在患者数量少和研究非对照的局限性,我们仍建议,大量被诊断为 IBS-D 或 IBS-M 的患者可能实际上只是单纯的功能性便秘,应按此进行治疗。
BMC Gastroenterol. 2020-4-6
Neurogastroenterol Motil. 2013-8-29
Am J Gastroenterol. 2021-2-1
Neurogastroenterol Motil. 2020-11
J Gastroenterol Hepatol. 2012-4
Gastroenterology. 2016-2-15
Gastroenterology. 2016-2-15
Gastroenterology. 2016-2-18
J Pediatr Gastroenterol Nutr. 2016-11
Pediatr Rev. 2015-9